Finally, increased expression of IGFBP2 is associated with progression in numerous cancers including glioma [35, 42, 57], ovarian [4, 15, 24], prostate [27, 51, 63], pancreatic [1, 28, 41], and breast cancer [68]. Here, IGFBP2 is linked to glioma.